Annual Healthcare Symposium

This year's theme: Innovation and Patient Access After the Inflation Reduction Act

18 Apr

Price: FREE

Thu, Apr 18, 2024

8:30AM - 1:20PM EDT

1 Washington Place Newark, NJ, 07102 | Bove Auditorium & 2nd Floor Lounge

The Inflation Reduction Act (IRA) of 2022 brought a tremendous change in the Medicare Part D Prescription Drug benefit operation and coverage. The Academia and the industry has been analyzing the impact of the IRA on the Bio Pharmaceutical R&D, Access to drugs by the elderly population in the USA, impact on drugs approvals, and employment. This will have a spillover effect on the prescription drugs in the private market. The symposium will bring together industry experts, academia and the patients advocacy groups to discuss in front of our students, and faculty, and give them an opportunity to interact with the experts in the form of Q&A session. The symposium is open to all students, faculty, and the industry executives. It is a free event.

Agenda

TIME	TOPIC
8:30 - 9:00 AM	Registration & Networking Breakfast
9:00 - 9:10 AM	Introduction Mahmud Hassan Director, The Blanche and Irwin Lerner Center for the Study of Pharmaceutical Management Issues
9:10 - 9:20 AM	Welcome Address Lei Lei, Ph.D. Dean, Rutgers Business School
9:20 - 9:30 AM	Remarks Michael Lerner, JD Chairman, Lener Center Board Partner, and Chair, Life Sciences Group Lowenstein Sandler LLP
9:30 - 9:40 AM	Life and Legacy of Irwin Lerner Ken Berkowitz Former Assistant General Counsel, Vice President, Public Affairs, Drug Regulatory Affairs and Drug Safety, Hoffmann-La Roche, Inc
9:40 - 10:05 AM Q&A 10:05 - 10:35 AM	Keynote Presentation and Q&A Paul Hastings President & CEO, Nkarta Therapeutics Inc
10:35 - 10:50 AM	Break
10:50 - 11:50 AM Q&A 11:50 - 12:20 PM	Innovation and Patient Access After the Inflation Reduction Act Leadership Panel Discussion and Q&A Panel Moderator Richard Bagger, JD Former Executive Vice President, Corporate Affairs and Market Access, Celgene Adjunct Faculty Member, Eagelton Institute, Rutgers University Panel Members Neal Masia, PhD Co-Founder and Chief Executive Officer, EntityRisk, Adjunct Professor Columbia University John M. O'Brien, PharmD, MPH President and CEO of the National Pharmaceutical Council Patricia J. Goldsmith Former Chief Executive, Officer of CancerCare Amadou Diarra Ph.D Former Senior Vice President of Global Policy, Patient Advocacy & Government Affairs, Bristol-Myers Squibb
12:20 - 1:20 PM	Networking Luncheon